ARMENIA, DANIELE
 Distribuzione geografica
Continente #
NA - Nord America 4.286
AS - Asia 1.263
EU - Europa 928
Continente sconosciuto - Info sul continente non disponibili 208
SA - Sud America 160
AF - Africa 42
OC - Oceania 3
Totale 6.890
Nazione #
US - Stati Uniti d'America 4.203
SG - Singapore 531
IT - Italia 327
CN - Cina 268
BD - Bangladesh 133
BR - Brasile 125
HK - Hong Kong 115
RU - Federazione Russa 114
VN - Vietnam 93
DE - Germania 84
SE - Svezia 84
IE - Irlanda 61
GB - Regno Unito 48
FR - Francia 45
CA - Canada 37
FI - Finlandia 30
UA - Ucraina 30
JP - Giappone 24
NL - Olanda 21
AT - Austria 19
IN - India 18
KR - Corea 18
AR - Argentina 15
PL - Polonia 13
IQ - Iraq 12
JM - Giamaica 11
BE - Belgio 10
ES - Italia 10
ID - Indonesia 10
MX - Messico 10
ZA - Sudafrica 10
CZ - Repubblica Ceca 9
CM - Camerun 7
CO - Colombia 6
NI - Nicaragua 6
KE - Kenya 5
MY - Malesia 5
TR - Turchia 5
CH - Svizzera 4
CR - Costa Rica 4
EC - Ecuador 4
EE - Estonia 4
IL - Israele 4
IR - Iran 4
RO - Romania 4
CL - Cile 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
EG - Egitto 3
HN - Honduras 3
MN - Mongolia 3
NP - Nepal 3
PH - Filippine 3
PK - Pakistan 3
TD - Ciad 3
TT - Trinidad e Tobago 3
VE - Venezuela 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
AU - Australia 2
BG - Bulgaria 2
KZ - Kazakistan 2
LT - Lituania 2
MA - Marocco 2
PE - Perù 2
SA - Arabia Saudita 2
TN - Tunisia 2
TW - Taiwan 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BJ - Benin 1
BS - Bahamas 1
BW - Botswana 1
CI - Costa d'Avorio 1
DZ - Algeria 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
GR - Grecia 1
GT - Guatemala 1
ML - Mali 1
MT - Malta 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
PY - Paraguay 1
RS - Serbia 1
SC - Seychelles 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
UY - Uruguay 1
Totale 6.685
Città #
Wilmington 836
Houston 651
Woodbridge 500
Singapore 310
Ashburn 249
Chandler 205
Beijing 175
San Jose 146
Fairfield 125
Hong Kong 111
Rome 93
Ann Arbor 77
Council Bluffs 71
Seattle 67
New York 64
Dublin 58
Los Angeles 54
Santa Clara 54
Cambridge 45
The Dalles 45
Medford 41
Munich 32
Hanoi 30
Dallas 29
Ho Chi Minh City 27
Tokyo 23
São Paulo 21
Helsinki 20
Dearborn 19
Milan 19
Lawrence 18
Lauterbourg 17
North Bergen 17
Orem 17
Creede 16
Nuremberg 16
Buffalo 15
Moscow 15
Jacksonville 14
Chicago 13
Colorado Springs 11
London 11
Montreal 11
Phoenix 11
San Francisco 11
Brussels 10
Denver 10
Naples 10
Atlanta 9
Florence 9
San Diego 9
Chennai 8
Jakarta 8
Vienna 8
Washington 8
Bologna 7
Brasília 7
Dong Ket 7
Seoul 7
Stockholm 7
Amsterdam 6
Boardman 6
Brno 6
Kingston 6
Managua 6
Manchester 6
New Orleans 6
Redondo Beach 6
Shanghai 6
Cagliari 5
Frankfurt am Main 5
Lappeenranta 5
Nairobi 5
Nepi 5
Perugia 5
Toronto 5
Warsaw 5
Baghdad 4
Binasco 4
Brooklyn 4
Columbus 4
Genoa 4
Johannesburg 4
Kraków 4
Las Vegas 4
Mumbai 4
Orlando 4
Paris 4
Poplar 4
Redwood City 4
Bari 3
Belo Horizonte 3
Birmingham 3
Boston 3
Falmer 3
Greenville 3
Haifa 3
Istanbul 3
Magenta 3
Manitou Springs 3
Totale 4.710
Nome #
Kinetics of hepatitis C virus RNA decay, quasispecies evolution and risk of virological failure during telaprevir-based triple therapy in clinical practice 506
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro 505
Next-generation sequencing provides an added value in determining drug resistance and viral tropism in Cameroonian HIV-1 vertically infected children 413
Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimen 395
Ultradeep sequencing detection of the R263K integrase inhibitor drug resistance mutation 393
Integrase strand transfer inhibitor-based regimen is related with a limited HIV-1 V3 loop evolution in clinical practice 380
Focus on recently developed assays for detection of resistance/sensitivity to reverse transcriptase inhibitors 320
Resistance detected in PBMCs predicts virological rebound in HIV-1 suppressed patients switching treatment 319
Impact of integrase polymorphisms and minor quasispecies in HIV-1 infected individuals naive or treated with strand-transfer integrase inhibitors: a refined analysis by cloning and 454-pyrosequencing techniques 312
HCV resistance compartmentalization within tumoral and non-tumoral liver in transplanted patients with hepatocellular carcinoma 275
HIV MDR is still a relevant issue despite its dramatic drop over the years 265
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry 172
HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015-21 162
Temporal trend of drug-resistance and APOBEC editing in PBMC genotypic resistance tests from HIV-1 infected virologically suppressed individuals 160
Viral resistance burden and APOBEC editing correlate with virological response in heavily treatment-experienced people living with multi-drug resistant HIV 154
Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settings 152
CMV seroprevalence and coronary CMV-DNA detection in immunocompetent patients with heart diseases 148
High performance of integrase genotyping on diverse HIV-1 clades circulating in Cameroon: toward a successful transition to dolutegravir-based regimens in low and middle-income countries 145
Detection of Gag C-terminal mutations among HIV-1 non-B subtypes in a subset of Cameroonian patients 139
Evaluation of virological response and resistance profile in HIV-1 infected patients starting a first-line integrase inhibitor-based regimen in clinical settings 129
Genotypic HIV-1 tropism determination might help to identify people with exhausted treatment options and advanced disease 129
Evaluation of Viral Suppression in Paediatric Populations: Implications for the Transition to Dolutegravir-Based Regimens in Cameroon: The CIPHER-ADOLA Study 128
A high genetic heterogeneity in HBsAg can affect immunogenicity in acute hepatitis B infection. 121
Bictegravir/emtricitabine/tenofovir alafenamide ensures high rates of virological suppression maintenance despite previous resistance in PLWH who optimize treatment in clinical practice 120
Genotypic Resistance Testing of HIV-1 DNA in Peripheral Blood Mononuclear Cells 117
Evaluation of HIV-1 capsid genetic variability and lenacapavir (GS-6207) drug resistance-associated mutations according to viral clades among drug-naive individuals 117
Genetic signatures specifically clustered in immune active HBsAg regions correlate with immunosuppression-driven HBV reactivation: An extensive analysis of HBV genome. 113
Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings 98
Role of low-frequency integrase strand transfer inhibitor resistance mutations on virological outcomes in antiretroviral therapy-naïve individuals initiating second-generation integrase inhibitors 95
Tenofovir and Doravirine Are Potential Reverse-Transcriptase Analogs in Combination with the New Reverse-Transcriptase Translocation Inhibitor (Islatravir) Among Treatment-Experienced Patients in Cameroon: Designing Future Treatment Strategies for Low- and Middle-Income Countries 80
Virological response and resistance profile in highly treatment-experienced HIV-1-infected patients switching to dolutegravir plus boosted darunavir in clinical practice 80
null 74
Poor CD4/CD8 ratio recovery in HBcAb-positive HIV patients with worse immune status is associated with significantly higher CD8 cell numbers 50
Persistence of CXCR4-tropic virus in people living with four-class drug-resistant HIV and its clinical impact in the modern antiretroviral era 47
Evaluation of HIV-1 transmitted drug-resistance among subtypes circulating from 2022 to 2024 in Italy: a refined analysis through next-generation sequencing 45
Confirmed virological failure following enhanced adherence counseling among virally unsuppressed children and adolescents on dolutegravir-based versus other regimens: Evidence from a cohort analysis in Cameroon 32
Totale 6.890
Categoria #
all - tutte 22.913
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.913


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022237 0 0 0 16 4 12 18 5 83 24 14 61
2022/2023519 44 62 51 55 48 73 22 76 44 22 11 11
2023/2024173 27 2 8 12 14 31 12 18 6 15 5 23
2024/2025979 30 154 112 55 38 41 117 48 103 69 51 161
2025/20261.726 156 51 133 183 156 60 219 154 171 166 131 146
2026/2027622 101 85 241 195 0 0 0 0 0 0 0 0
Totale 6.890